Previously, we have shown that nuclear extracts from cultured mouse keratinocytes induced to dierentiate by increasing the levels of extra-cellular calcium contain Fra-1, Fra-2, Jun B, Jun D and c-Jun proteins that bind to the AP-1 DNA binding sequence. Despite this DNA binding activity, AP-1 reporter activity was suppressed in these cells. Here, we have detected the CREB family proteins CREB and CREMa as additional participants in the AP-1 DNA binding complex in dierentiating keratinocytes. AP-1 and CRE DNA binding activity correlated with the induction of CREB, CREMa and ATF-1 and CREB phosphorylation at ser 133 (ser 133 phospho-CREB) in the transition from basal to dierentiating keratinocytes, but the activity of a CRE reporter remained unchanged. In contrast, the CRE reporter was activated in the presence of the dominantnegative (DN) CREB mutants, KCREB and A-CREB, proteins that dimerize with CREB family members and block their ability to bind to DNA. The increase in CRE reporter activity in the presence of these mutants suggests that CRE-mediated transcriptional activity is suppressed in keratinocytes through protein-protein interactions involving a factor that dimerizes with the CREB leucine zipper. In experiments where the A-CREB mutant was co-transfected with an AP-1 reporter construct, transcriptional activity was also increased indicating that a CREB family member binds AP-1 sites and represses AP-1 transcriptional activity as well. Exogenous expression of the transcriptional repressor CREMa down-regulated both CRE and AP-1 reporters in keratinocytes suggesting that this factor may contribute to the suppression of AP-1 transcriptional activity observed in dierentiating keratinocytes.
Introduction
Epidermal cell dierentiation requires the conversion of proliferative basal cells into the terminally differentiated enucleated squames that comprise the outer, protective barrier of the skin. This process is characterized by step-wise changes in cellular morphology, communication potential, loss of cellular organelles, withdrawal from the cell cycle and both the induction and suppression of gene expression (reviewed by Yuspa 1994; Fuchs and Byrne 1994; Watt and Jones 1993) . The transcriptional events that control the dierentiation process in epidermal cells have not been well-de®ned.
Previously we have shown that members of the AP-1 transcription factor family partition to dierent layers of newborn mouse epidermis; c-Jun, Jun B, Jun D, Fra-1 and Fra-2 were detected in the basal layer, Jun D and Fra-1 in the spinous layer, and only Fra-2 and Jun B were expressed in granular layer cells (Rutberg et al., 1996) . This suggested that distinct AP-1 heterodimers are formed during the dierent stages of epidermal dierentiation and thus, the AP-1 transcription factor may have distinct functions in the dierent layers of the skin. Studies in cultured cells indicated that AP-1 transcriptional activity is down-regulated in mouse keratinocytes induced to dierentiate by raising the extracellular calcium and that the Fra-2:jun B heterodimer negatively regulates AP-1-mediated gene expression in these cells. In contrast, when c-Fos was induced in keratinocytes, by treatment with 12-Otetradecanoyl-phorbol-13-acetate (TPA), AP-1 sites were transcriptionally activated and the c-Fos:Jun B heterodimer induced AP-1 transcriptional activity (Rutberg et al., 1997) . These results indicate that the composition of the AP-1 DNA binding complex, as determined by the in¯uence of media components, cellular environment and possible interactions with related transcriptional regulators, determines the degree of AP-1 trans-activation in keratinocytes.
The similarities between the AP-1 (TGA[G/C]TCA target binding sequence and the cyclic AMP response element (CRE; TGACGTCA) raises the possibility that overlap may occur between the DNA binding activities of AP-1 and CRE families of DNA binding proteins in basal and/or dierentiated keratinocytes. Originally identi®ed for the signal transduction of nuclear eects of PKA activation (Hoeer et al., 1988; Gonzalez et al., 1989) , the cyclic AMP response element binding (CREB) protein is a basic/leucine zipper (B-ZIP) transcription factor that functions in vivo to regulate the proliferation of pituitary cells (Struthers et al., 1991) and thymocytes (Barton et al., 1996) and contributes to the establishment of circadian rhythms (Foulkes et al., 1996) . The CREB family (de®ned by cross-dimerization and homology in the basic and leucine zipper domains) consists of multiple isoforms of CREB, multiple isoforms of the cyclic AMP-response element protein modulator (CREM), and Activating Transcription Factor (ATF)-1. Encoded by separate genes, these factors comprise a cyclic AMP-responsive subset of the CRE DNA binding proteins. CREB, CREM and ATF-1 readily form heterodimers, and bind to CRE target sequences with similar speci®city (reviewed in Meyer and Habener 1993; Sassone-corsi 1995) . CREB is a transcriptional activator when phosphorylated at the ser 133 phospho-acceptor site (Gonzalez et al., 1989) , and a repressor of transcriptional activity in the hypo-phosphorylated state (O®r et al., 1991; Hagiwara et al., 1992) . With the exception of the CREMt isoform, the CREM (and related ICER) proteins are negative regulators of transcriptional activity mediated by the CRE target sequence (Molina et al., 1993; Foulkes et al., 1991) . The balance of positive and negative eects of the CREB and CREM regulators, respectively, allows these factors to ®ne tune gene regulatory events as has been demonstrated recently with the establishment of circadian rhythms in the rat pineal gland (Foulkes et al., 1996) . The potential for the CREB family of transcription factors to induce and suppress gene expression also renders them ideally suited for regulating gene expression during the process of epidermal dierentiation.
Since many of the marker genes of keratinocyte dierentiation contain AP-1 binding sites in regulatory positions, interactions between the AP-1 and CRE DNA binding proteins could be important in establishing patterns of gene expression in the epidermis. Crosstalk in the form of binding of AP-1 or CRE proteins to both AP-1 and CRE target binding sequences has been demonstrated (Masquilier and Sassone-corsi 1992; Hadman et al., 1993; Hai and Curran 1991; Pestell et al., 1994) , and the ability of AP-1 and CRE DNA binding proteins to heterodimerize has been indicated in other systems (Hai et al., 1989; Hai and Curran 1991; Chatton et al., 1994; Ryseck and Bravo 1991) . This study examines the expression patterns and DNA binding activities of CREB, CREMa and ATF-1 in basal and dierentiating keratinocytes. Using dominant-negative (DN) mutants (A-ZIP) mutants Ahn et al., 1998 , Olive et al., 1997 that dimerize with the CREB and Fos families of transcription factors and inhibit their ability to bind to DNA, we have established that both Fos and CREB proteins bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in primary cultures of dierential keratinocytes.
Results

Activities of AP-1 and CRE DNA binding proteins in keratinocytes
The AP-1 proteins Fra-1, Fra-2, c-Jun, Jun B and Jun D are expressed in keratinocytes induced to differentiate in vitro by raising the extracellular calcium from 0.05 to 0.12 mM. Together, these factors create an AP-1 DNA binding complex that peaks in intensity 48 h after the calcium shift (Rutberg et al., 1996) . To determine whether CRE DNA binding proteins also interact with the AP-1 target sequence in dierentiated mouse keratinocytes, we performed EMSA reactions utilizing 32 P-labeled AP-1 and CRE binding sequences reacted with nuclear extracts prepared from keratinocytes 48 h after shifting the calcium concentration to 0.12 mM (Figure 1a ). DNA binding complexes of a similar size and intensity were formed with both the AP-1 and CRE target sites. Shorter exposures of the gels presented in Figure 1a indicates that the AP-1 and CRE DNA binding complexes consist of multiple bands that migrate very close together and that these bands contribute to the appearance of one large AP-1 and CRE DNA binding complex (see Figure 1d ). Unlabeled AP-1 and CRE oligomers competed for binding to both the 32 P-labeled AP-1 and CRE target sequences indicating that both AP-1 and CRE binding proteins interact with the AP-1 (and CRE) target sequence in these cells. No inhibition of binding activity was seen in the presence of an oligomer bearing the unrelated SP-1 binding site (Figure 1a) .
In a second approach to examine the potential involvement of CREB family proteins in the AP-1 DNA binding complex, we have included dominantnegative (DN) mutant proteins (described in Olive et al., 1997; Ahn et al., 1998) which inhibit the binding of Fos family (A-Fos), CREB family (A-CREB) and VBP (A-VBP) proteins to DNA in the binding reactions. The addition of the A-FOS or A-CREB mutants to the reaction decreased the binding of the extracts to the 32 P-labeled AP-1 sequence to a similar extent ( Figure  1b ). This supports that both Fos and CREB family proteins bind to the AP-1 DNA binding sequence. CRE DNA binding activity was slightly inhibited by the addition of the A-FOS mutant to the DNA binding reaction (compared with the A-VBP control), whereas the A-CREB mutant completely blocked CRE DNA binding activity. These data indicate that the CRE DNA binding proteins consist primarily of CREB family proteins while the AP-1 DNA binding proteins are a mixture of AP-1, CREB and potentially other families of transcriptional regulators.
To con®rm that the A-FOS mutant does not dimerize with CREB and therefore that the results in Figure 1b are indicative of CREB proteins binding to the AP-1 target sequence, the A-FOS mutant was included in a DNA binding reaction containing puri®ed CREB protein and a 32 P-labeled CRE oligomer. As shown in Figure 1c , the binding of CREB was blocked completely in the presence of a onefold molar excess of A-CREB mutant whereas this binding activity remained unaected by up to a 100-molar excess of the A-FOS or A-C/EBP dominantnegative mutants.
In an attempt to identify the factors that bind to the AP-1 and CRE sequences, antibodies speci®c for the Fos family, c-Jun, Jun B and Jun D and the CREB family proteins were included in the DNA binding reaction (Figure 1d ). Using this approach, CREB, CREMa, ATF-1, Jun D and a Fos protein were identi®ed as proteins that interact with the CRE target sequence due to the ability of antibodies against these proteins to diminish the intensity of the DNA binding complex and to form a super-shifted band. The use of an antibody directed against the phosphorylated form of the ser 133 residue of CREB (Ginty et al., 1993 ) also detected the presence of phospho-ser 133 CREB in the CRE-DNA binding complex. In addition to Fos and Jun proteins, CREB and CREMa bound to the AP-1 target sequence, potentially accounting for the CRE DNA binding component of the AP-1 DNA binding complex. Because the supershift assay is not quantitative, it is not possible to establish either the relative anities of these proteins for the AP-1 and CRE target sequences or the extent to which these factors contribute to the intensity of the DNA binding complex. Nevertheless, these data identify the particular AP-1 and CRE binding proteins that interact with both the AP-1 and CRE target sequences in dierentiated keratinocytes.
CRE DNA binding activity in keratinocytes in vitro
To determine the DNA binding activity of CREB proteins in keratinocytes, a time course analysis was performed. Low levels of CRE DNA binding activity were detected in basal keratinocytes, while a large molecular weight CRE DNA binding complex was formed 24 h after the calcium shift ( Figure 2 ). This complex peaked in intensity by 48 h, and diminished in intensity by 72 h. The maximal binding activity at 48 h correlates with the induction of granular layer marker genes and the repression of spinous layer genes in vitro (Yuspa et al., 1989) , and mimicked the time course of AP-1 DNA binding activity in keratinocytes (Rutberg et al., 1996) .
Expression of CRE DNA binding proteins in basal and dierentiating keratinocytes
To correlate the levels of CRE DNA binding activity with the expression of the CREB family proteins that bind to the CRE in dierentiating keratinocytes, Western blot analysis was performed using nuclear and cytoplasmic extracts from basal keratinocytes and cells harvested 48 h after the calcium shift ( Figure 3) . A CREB doublet migrating at 43 kDa (consistent with the reported size of the CREB 341 isoform, Hoeer et al., 1988; Gonzalez et al., 1989) was detected in the nuclear fraction of both basal and dierentiated keratinocytes. The intensity of this doublet increased dramatically in extracts from dierentiated keratinocytes. Single bands were detetected with antibodies against CREMa and ATF-1. The protein detected with the antibody directed against CREMa was found in both cytoplasmic and nuclear fractions of basal and dierentiated keratinocytes ( Figure 3 ) and corresponded in size with a CREMa cDNA exogenously expressed in keratinocytes (not shown). The levels of CREMa increased in dierentiated keratinocytes, although to a lesser extent than the CREB doublet. ATF-1 was detected only in the nuclear fraction of dierentiating keratinocytes indicating that ATF-1 expression is signi®cantly induced in dierentiating keratinocytes. The size of ATF-1 is consistent with other reports (Kelly et al., 1995; Brown et al., 1995) . Forty-eight hours were required for the maximal induction of CREB and ATF-1 while CREMa was induced 24 h after the calcium shift (data not shown). Pre-treatment of keratinocytes with cycloheximide (20 mg/ml) prior to the calcium shift blocked the induction of CREB, CREMa and ATF-1 indicating that de novo synthesis of these proteins occurs in response to the calcium signal for dierentiation.
Localization of CRE binding proteins in primary keratinocytes in vitro and mouse skin in vivo
In order to con®rm the expression patterns of CREB, CREMa and ATF-1 proteins in basal and differentiating keratinocytes in vitro, immunocytochemical reactions were performed (Figure 4a ). The expression of CREB and CREMa was localized to the nuclear component of basal cells; cytoplasmic expression of CREMa was not detected with this approach. The intensity of the nuclear staining for CREB and CREMa increased in dierentiating keratinocytes and ATF-1 was detected in the nuclei of these cells as well. These proteins appeared to be localized to the islands of dierentiated cells that are present in cultures of calcium-shifted keratinocytes. Phospho-ser 133 CREB was detected only in cultures of dierentiated keratinocytes. In an attempt to localize the expression of CREB proteins in vivo, immunostaining reactions were performed using skin from newborn mice. As shown in Figure 4b , CREB, CREMa and ATF-1 were abundant in nuclei throughout the basal and spinous layers, and none of these factors were detected in the granular layer of newborn mouse skin. This analysis indicates that CREB proteins are abundant in newborn mouse epidermis, and that there are dierences in the expression or detection of these factors in basal keratinocytes between the in vitro and in vivo environments.
Phosphorylation status of CREB in dierentiating keratinocytes
To investigate the nature of the upper band of the CREB doublet in dierentiated keratinocytes, nuclear extracts prepared from keratinocytes 48 h after the calcium shift were incubated with calf-intestinal alkaline phosphatase prior to Western blot analysis. As a result of this treatment, the CREB doublet was reduced to a single band (Figure 5a ), indicating that CREB exists as a phosphoprotein in dierentiated keratinocytes. This is consistent with the ability of the phospho-ser 133 CREB antibody to supershift the CRE DNA binding complex and the detection of phosphoser 133 CREB in cultures of dierentiated keratinocytes, although the phosphorylation of CREB may occur at other residues as well. The migration of CREMa and ATF-1 remained unaected by phosphatase treatment. Inhibitors that block the activities of PKA and calcium-calmodulin dependent kinases failed to inhibit the formation of the CREB doublet in dierentiating keratinocytes (data not shown) suggesting that kinases in other signaling pathways phos- (7) to 0.12 mM (+) were reacted in EMSA with a 32 P-labeled CRE target sequence. Duplicate samples were prepared at each time point Figure 3 Expression patterns of CRE DNA binding proteins in basal and dierentiated keratinocytes. Cytoplasmic (C) and nuclear (N) extracts were prepared from basal keratinocytes (maintained in 0.05 mM calcium) and from keratinocytes 48 h after raising the calcium concentration to 0.12 mM in the presence or absence of 20 mg/ml of cycloheximide as indicated. The expression of CREB, CREMa and ATF1 was detected using speci®c antibodies. The molecular weights of the proteins (kDa) are shown on the right-hand side of the ®gure phorylate CREB in these cells. To determine whether the activation of PKA causes ser 133 phosphorylation of CREB in keratinocytes, we have treated both NIH3T3 cells and basal keratinocytes with cyclic AMP analog, dibutyryl cyclic AMP. In this analysis, we found that neither a 1- (Figure 5b ) nor a 4-h treatment (not shown) stimulated ser 133 CREB phosphorylation as detected with the phospho-ser 133 speci®c antibody. In contrast, we observed a threefold increase in the amount of phospho-ser 133 CREB in NIH3T3 cells treated for 1 h in parallel. Thus, the ability to activate CREB through stimulation of the PKA signaling pathway appears to dier between keratinocytes and NIH3T3 cells.
CRE-mediated transcriptional activity in keratinocytes
To evaluate the levels of transcriptional activity mediated by the CRE target sequence in keratinocytes, a CRE reporter bearing ®ve tandem repeats of the CRE target sequence (56CRE) was constructed (as described in the Materials and methods). This CRE reporter was activated threefold by the addition of 1 mM dibutyryl cyclic AMP to the medium of transfected NIH3T3 cells (Figure 6a ). In keratinocytes, only a slight increase in CRE-CAT activity occurred 24 h after the calcium shift whereas CAT activity remained unchanged from that in basal cells after 48 h (Figure 6b) . Thus, the strong CRE DNA 
Depression of CRE transcriptional activity in keratinocytes
To examine whether a negative regulatory factor that dimerizes with a CREB family protein contributes to the low levels of CRE transcriptional activity in keratinocytes, the CRE reporter was co-transfected with two dierent dominant-negative (DN) CREB constructs (A-CREB and KCREB) into basal keratinocytes. The cells were calcium-shifted and harvested 24 h later. KCREB is a naturally occurring CREB mutant with an arginine to leucine substitution in the DNA binding domain (Walton et al., 1992) . This mutation prevents KCREB from binding to DNA, and as a result, KCREB:CREB heterodimers are transcriptionally inactive. The A-CREB construct encodes a protein containing the CREB leucine zipper and Cterminus. In this case, the CREB DNA binding region has been replaced by an amphipathic acidic extension designed to stabilize the formation of the heterodimer while preventing interactions with DNA (as described in Krylov et al., 1995; Olive et al., 1997) . Cotransfection of KCREB with the CRE reporter caused a threefold increase in CRE transcriptional activity (Figure 7a ). Co-transfection of the CRE reporter with A-CREB caused a 7 ± 10-fold increase in transcriptional activity whereas A-ZIP DN constructs speci®c for the Fos (A-FOS) and C/EBP (A-C/EBP) (Olive et al., 1997; Ahn et al., 1998) families of transcription factors did not alter CRE reporter activity (Figure 7b ). Constructs encoding either the CREB leucine zipper but not the acidic extension (OH-CREB), or the wildtype CREB C-terminus, leucine zipper and basic region, but not the transactivation domain (B-CREB) failed to alter the activity of the CRE reporter ( Figure  7b ) indicating that the acidic extension is required for the observed eect of the A-CREB mutant.
To test whether CREB proteins have the ability to repress the activity of an endogenous promoter, we have transfected a construct bearing wild-type and CRE mutant forms of the TGFb3 promoter (cloned upstream of the CAT gene) into basal keratinocytes. This promoter has been previously shown to have a functional CRE that is linked to TGFb3 expression (Lafyatis et al., 1990) . The calcium concentration was raised and the cells were harvested 24 h later. As shown in Figure 7c , the activity of the mutated construct was signi®cantly greater than the wild-type indicating that factors binding to the CRE site have a negative role in regulating the promoter activity.
Functional consequences of interactions of CREB proteins with the AP-1 target sequence
The apparent overlap in speci®city of the AP-1 and CRE DNA binding proteins in EMSA raises the possibility that CREB family proteins in¯uence AP-1 transcriptional activity in keratinocytes. To test this possibility, A-CREB and A-FOS mutants were cotransfected with a reporter construct bearing a 56multimer of the AP-1 target sequence (56TRE-CAT Angel et al., 1987) into basal keratinocytes. The concentration of calcium in the medium was raised to 0.12 mM and the cells were harvested 24 h later. As shown in Figure 8a , the AP-1 reporter was activated by both the A-CREB and A-FOS mutants. Since A-CREB and A-FOS interfere with the DNA binding activity of CREB and FOS proteins, respectively, these results indicate that both families of proteins bind to the AP-1 sequence and contribute to the downregulation of AP-1 transcriptional activity in differentiating keratinocytes. To ensure that the activation of the AP-1 reporter was speci®c to the A-CREB and A-FOS constructs, we performed analogous experiments with a C/EBP DN mutant (A-C/EBP). In repeated experiments, the levels of AP-1 activity in the presence of A-C\EBP were never signi®cantly dierent from the values obtained in the presence of the CMV500 construct (data not shown).
The CREM isoforms are known to be transcriptional repressors. Since CREMa binds to the AP-1 target sequence (Figure 1d) , we examined the ability of CREMa to repress AP-1 reporter activity in keratinocytes. For this, a CREMa expression vector was cotransfected with the AP-1 reporter into basal keratinocytes. The cells were calcium-shifted and harvested 24 h later. In the same experiments, the CREMa DNA was also co-transfected with the CRE reporter to con®rm the ability of CREMa to repress CRE-mediated transcriptional activity. As shown in Figure 8b , CREMa inhibited the activity of the CRE The CRE reporter was co-transfected with A-ZIP DN constructs designed to dimerize with CREB (A-CREB), Fos (A-FOS) and C/EBP (A-C/EBP) family proteins while preventing their binding to DNA. CMV500 (as described in Ahn et al., 1998) is the parental vector used here; B-CREB and OH-CREB represent control constructs described in the Materials and methods and Results. In a and b, the values have been normalized to the activity of the parental pBLCAT2 construct. (c) Wild-type and CRE mutant forms of the TGFb3 promoter were transfected into basal cells. The calcium concentration was raised to 0.12 mM, and the cells were harvested 24 h later. The data shown are from a representative experiment that was replicated twice reporter by at least 50% in four of four experiments tested. CREMa inhibited the activity of the AP-1 reporter to a similar extent in two of four experiments (a representative of which is shown in Figure 8b ) but was ineective in the other two. These results suggest that CREMa may be a factor that binds to the AP-1 target sequence and suppresses AP-1 transcriptional activity in keratinocytes but there may be speci®c culture conditions that contribute to CREMa activity as an AP-1 inhibitory factor.
Discussion
This study establishes that CRE DNA binding proteins bind to the AP-1 target sequence and in¯uence AP-1 transcriptional activity in keratinocytes. Both a CRE oligomer and a CREB family DN mutant protein partially blocked AP-1 DNA binding activity, and CREB family proteins were identi®ed as components of the AP-1 DNA binding complex in dierentiating keratinocytes. Transcriptional assays utilizing CRE and AP-1 reporters co-transfected with CREB and Fos family DN constructs indicated that both families of proteins suppress AP-1 reporter activity in differentiating keratinocytes. In vivo, CREB, CREMa and ATF-1 were localized in the basal and spinous layers of newborn mouse skin, and all of these proteins were induced in dierentiating keratinocytes in vitro. Altogether, these data support that AP-1 and CRE binding proteins are expressed in parallel in keratinocytes in vitro and in vivo and that members of each family bind to the AP-1 binding sequence and suppress AP-1 transcriptional activity in dierentiating keratinocytes.
CREB is phosphorylated at the ser 133 site in dierentiating keratinocytes, as shown through immunostaining and Western blotting using an antibody speci®c for ser 133 phospho-CREB. Despite the presence of both the activated form of CREB and a strong CRE DNA binding complex in our nuclear extracts, transcriptional activity driven by a CRE reporter was very low in dierentiated keratinocytes. However, CRE-mediated transcriptional activation was increased in keratinocytes co-transfected with the independently generated CREB DN mutants A-CREB and KCREB, and the activity of the TGFb 3 promoter was elevated in the absence of a functional CRE site providing supportive evidence for a role of CRE binding proteins as transcriptional repressors in dierentiating keratinocytes. Both of the CREB mutants achieve a dominant-negative eect through dimerizing with CREB family proteins and preventing their interaction with DNA. Although activation of the CRE was achieved with both the KCREB and A-CREB mutants, the A-CREB mutant was more eective. This observation is consistent with the design of the mutant and the ability of the acidic extension to stabilize dimer formation between the dominantnegative and the endogenous B-ZIP protein (Krylov et al., 1995) . In keratinocytes, these mutants may inhibit a repressor that is either dominant, but less abundant than, or distinct from, proteins that activate the CRE. Alternatively, KCREB and A-CREB may selectively inhibit speci®c members of the CREB family that have a repressive function; the relative anities of the DN mutants for CREB family proteins has not been reported.
Our data suggest that CREMa is a repressor of CRE transcriptional activity in keratinocytes. This is consistent with the role of CREMa, b and g and the ICER isoforms as strong inhibitors of transcription, even at low concentrations (Laoide et al., 1993; Walker et al., 1996; Molina et al., 1993) . We found that the levels of CREMa are greater in dierentiated keratinocytes when compared with basal cells in vitro and that exogenous expression of CREMa negatively regulates the CRE reporter in keratinocytes. Interference of the repressor function of CREMa by the DN CREB mutants could allow as yet unidenti®ed activator protein(s) to positively regulate AP-1 and CRE transcriptional activity in keratinocytes. Alternative targets of the A-CREB and KCREB mutants include CREB itself which exists in dierent phosphorylation states in keratinocytes and the transcriptional repressor, CREB-2 (Karpinski et al., 1992) , that binds to the CRE without interacting with CRE activator proteins. Altering the ratios of activated and nonactivated forms of CREB through interactions with the DN constructs could result in dierences in the overall a b Figure 8 CREB family proteins repress AP-1 transcriptional activity. (a) Basal keratinocytes were transfected with a 56TRE reporter construct and either the parental CMV500, A-CREB or A-FOS plasmids as indicated. The cells were calcium-shifted and harvested 24 h later. The data shown represents mean+s.e.m. for ten pooled experiments comparing A-CREB with A-CMV500 and six pooled replicates comparing all three vectors. (b) Basal keratinocytes were co-transfected with either the CRE or AP-1 reporters and the parental Rc/RSV (control) or RSV-CREMa constructs. The cells were calcium-shifted and harvested 24 h later. The experiment shown is representative of data that have been replicated twice for the TRE-CAT and four times for the CRE-CAT activity of CRE DNA binding proteins in keratinocytes; blocking CREB-2 activity would inhibit this repressor without also limiting the ability of activator CREB proteins to bind to and trans-activate the CRE reporter.
In contrast to our observations here where the A-CREB mutant appears to restore suppressed levels of CRE transcriptional activity, the A-CREB mutant blocked cyclic AMP-induced CRE transcriptional activity in PC12 cells when co-transfected with either a minimal promoter bearing a single CRE binding site or a 750 base pair region of the c-Fos promoter (Ahn et al., 1998) . With this in mind, it appears that the activities of the CREB family proteins in epidermal keratinocytes are dierent in some way from those in other cell types. Cyclic AMP agonists are strong inducers of CRE reporter activity in PC12 cells whereas treatment of keratinocytes with a cell permeable cyclic AMP analog failed to induce either ser 133 phosphorylation of CREB or CRE transcriptional activity in keratinocytes. These ®ndings raise the possibility that CREB family proteins may have a unique function in these cells. Experiments designed to study the role of CREB proteins in keratinocytes are currently in progress in an attempt to address this issue.
CREB proteins appear to bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in keratinocytes as determined through EMSA and by co-transfecting A-CREB with the AP-1 reporter construct. The AP-1 reporter was co-transfected with the A-FOS mutant as well to provide a context in which to interpret the data obtained with A-CREB. Both mutants caused an increase in AP-1 transcriptional activity in keratinocytes. Previously, we have shown that Fra-2 is abundant in dierentiated keratinocytes and that this protein negatively regulates AP-1 transcriptional activity in these cells. Since homodimers between members of the Fos family do not occur, the activation of the AP-1 reporter in the presence of the A-FOS mutant is consistent with blocking the activity of Fra-2 through the formation of inactive dimers between A-FOS and the B-ZIP proteins that normally dimerize with Fra-2. By squelching the activity of Fra-2 in this way, activator proteins would be able to bind to and activate the AP-1 target sequence. Although we have not identi®ed the factors that activate the AP-1 target sequence in the presence of A-FOS, previous results indicate that c-Jun, Jun B and Jun D are abundant in differentiating keratinocytes (Rutberg et al., 1996) . Interestingly, A-CREB also activated the AP-1 reporter, a result that is consistent with A-CREB squelching the activities of a negative transcriptional regulator such as CREMa that may bind to and suppress the activity of the AP-1 target sequence. That signi®cant activation of the AP-1 reporter occurred upon cotransfection with A-CREB despite a relatively weak supershift with antibodies against CREB family proteins may indicate that the CREB-related repressor is eective at very low concentrations, a known characteristic of CREM repressors (Laoide et al., 1993) . Together, these data suggest that a Fos protein such as Fra-2 and a CREB protein such as CREMa may bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in dierentiating keratinocytes.
The demonstration that CREB, CREMa and ATF-1 are induced in dierentiating keratinocytes contributes three additional proteins to the array of B-ZIP transcription factors that are up-regulated in calciumtreated primary mouse keratinocytes in vitro. Additional factors include Jun B, Fra-2 and Jun D (Rutberg et al., 1996) . Fra-2, Jun B (Claude Backendorf, personal communication) and Tst-1 and Skn-1 (Andersen et al., 1977) have also been identi®ed in dierentiating human keratinocytes in vitro. We have shown here and elsewhere (Rutberg et al., 1996 (Rutberg et al., , 1997 that c-Jun, Jun B, Jun D, Fra-1, Fra-2, CREMa and CREB bind to the AP-1 target sequence in differentiating keratinocytes in vitro. Based on the localization of AP-1 and CREB proteins in newborn mouse skin, it is possible that CREB and Fos proteins moderate the levels of AP-1 transcriptional activity during dierent stages of epidermal dierentiation. CREMa is localized to both the basal and spinous layers while Fra-2 is con®ned to the basal and granular layers of mouse skin. Thus, a factor which has the potential to suppress AP-1 transcriptional activity is present at each stage of keratinocyte dierentiation in vivo. Whether negative regulation is actually observed in vivo, however, is likely to re¯ect the dynamic array of AP-1 and CRE transcriptional regulators expressed in a cell at any given time. Keratinocyte marker genes that contain AP-1 DNA regulatory sequences include transglutaminase-1 (Yamada et al., 1994; Yamanishi et al., 1992) , pro®laggrin (Presland et al., 1992; Jang et al., 1996) , involucrin (Lopez-Bayghen et al., 1996; Takahashi and Iizuka 1993) , keratin 1 (Hu et al., 1993; Lu et al., 1994; Zhang et al., 1994) , keratin 5 (Casatorres et al., 1994) , keratin 6 (Navarro et al., 1995; Bernerd et al., 1993) and keratin 18 (Oshima et al., 1990) , loricin (DiSepio et al., 1995) and spr1 (Reddy et al., 1996) ; of these genes, the spr1 gene also contains a CRE sequence in a known regulatory position (Reddy et al., 1996) . Thus, there is a wide range of keratinocyte genes with the potential for regulation by AP-1 and/or CRE binding proteins.
Considering the abundance of keratinocyte genes that are regulated by AP-1 target sequences, it is logical that mechanisms would evolve to both induce and suppress gene expression from AP-1 sites. With this in mind, the role of CRE binding proteins in the epidermis may be to (1) regulate gene expression at CRE target sites and (2) modify the expression of AP-1 regulated genes through binding to the AP-1 target sequence. The abundance and dierential expression of factors belonging to the AP-1 and CRE families in epidermal keratinocytes suggests important functions for these proteins during the formation of the epidermis. Dysregulation of the transcriptional process regulated by these factors may contribute to pathological conditions in the skin.
Materials and methods
Cell culture
Primary mouse keratinocytes were isolated and maintained in medium with 0.05 mM calcium and 8% chelex-treated fetal bovine serum (FBS) as described previously (Hennings et al., 1980; Rutberg et al., 1997) . After 7 days, the calcium concentration was raised to 0.12 mM by adding the appropriate amount of 300 mM CaCl 2 directly to the culture dish (this process is referred to as a`calcium shift' throughout the manuscript). NIH3T3 cells were maintained in Dulbecco's Modi®ed Minimal Essential Medium containing 10% FBS. Both the keratinocytes and the NIH3T3 cells were maintained at 378C in 7% CO 2 , 93% air. Keratinocytes and NIH3T3 cells treated with the cell permeable cyclic AMP analog, dibutyryl cyclic AMP (Calbiochem, San Diego, CA, USA), were maintained in 0.5% serum for 16 h prior to the addition of dibutyryl cyclic AMP directly to the medium. The cells were harvested 1 and 4 h later for preparation of nuclear extracts. TPA (162 nM, from LC Services) was added in EMEM containing 8% chelex-treated fetal bovine serum to transfected keratinocytes following a 6 h transfection period in serum-free medium. Cycloheximide (20 mg/ml, Sigma, St. Louis, MO, USA) was added to keratinocyte cultures 30 min prior to the calcium shift.
Electrophoretic mobility shift assay
Electrophoretic Mobility Shift Assay (EMSA) was performed as described previously (Rutberg et al., 1996) using 3 mg of nuclear extract (Schreiber et al., 1989) per reaction. DNA binding complexes were visualized using a 32 P-labeled probe bearing a single copy of the consensus AP-1 (5'-cgcttgaTGAGTCAgccggaa-3') or CRE (5'-agagattgccT-GACGTCA-gagagctag-3') target sequences. The AP-1, CRE and SP-1 oligomers were purchased from Promega (Madison, WI, USA). Competitive inhibition of binding was achieved by adding unlabeled competitor DNA, or A-ZIP mutant, to the reactions 10 min prior to the addition of radiolabeled probe. For the super-shift reactions, speci®c antibodies were added to the DNA binding reaction 10 min after the addition of radiolabeled probe.
Western blotting
Western blot analysis of nuclear extracts was performed as described previously (Rutberg et al., 1996 (Rutberg et al., , 1997 .
Immunostaining
Dorsal skin from 1 ± 2 day old Balb/c mice was embedded in Tissue-Tek OCT (Miles, Inc. Elkard, IN, USA) and frozen sections were prepared. The sections were ®xed in 4% formaldehyde for 10 min before immunoperoxidase staining as described previously (Tennenbaum et al., 1993) . The antibody against ATF-1 was biotinylated directly and used undiluted in the staining reaction, the antibodies against CREB and CREMa were reacted with a biotinylated secondary antibody in situ. In all cases, the reactive cells were visualized through the use of the standard ABC reagent (Vector Labs, Burlingame, CA, USA) together with DAB as the substrate (Sigma, St. Louis, MO, USA) and counterstained with Contrast Green (Kirkegaard and Perry Laboratories, Gaithersberg, MD, USA).
Transfection
Primary keratinocytes were transfected on day 6 after plating using the Lipofectamine Reagent (GIBCO, Grand Island, NY, USA) as described previously (Rutberg et al., 1997) . The lipid/DNA complexes were incubated with the cells (in triplicate) for 6 h in serum-free EMEM containing 0.05 mM calcium. Subsequently, medium containing 8% chelex-treated FBS and 0.05 mM calcium+dibutyryl cyclic AMP or TPA or 0.12 mM calcium alone was added and the cells were harvested 24 or 48 h later. NIH3T3 cells were transfected the day after plating using 4 mg of DNA and 12 ml of Lipofectamine Reagent per 60 mM dish in serum-free DMEM. After the 6 h transfection procedure, dibutyryl cyclic AMP in medium containing 10% FBS was added, and the cells were harvested 24 h later.
CAT assays
CAT assays were performed as described previously (Rutberg et al., 1997) . Each assay was performed in triplicate using three separate dishes for each condition. Results of the 56CRE and 56TRE reporters are expressed relative to the activity of the parent pBLCAT2 plasmid to ensure that the reported activity is due solely to the CRE or AP-1 DNA binding sequences on the vector (as described in Angel et al., 1987) . For the co-transfection experiments, expression vectors and 56reporters were transfected at a ratio of 2 : 1. In these experiments, equal amounts of parental or experimental expression vectors were used.
Plasmids, proteins and antibodies
The pBLCAT vector and the AP-1 reporter construct used in this study (56TRE CAT) (Angel et al., 1987) were obtained from M Karin (University of California at San Diego, La Jolla, CA, USA). The 56CRE was generated by inserting a 56multimer of the CRE target binding sequence (5'-GTTGACGTCACA-3') into the HindIII ± BamHI sites of pBLCAT2. The wild-type and mutated forms of the TGFb 3 promoter (Lafyatis et al., 1990) were obtained from S Kim (National Cancer Institute, Bethesda, MD, USA). CMV-500 and the A-ZIP vectors CMV-A-CREB, CMV-A-FOS, CMV-A-C/EBP, CMV-B-CREB and CMV-OH-CREB vectors have been described (Olive et al., 1997; Krylov et al., 1995; Ahn et al., 1998) . The RSV CREMa and RSVKCREB expression vectors were obtained from R Goodman (Oregon Health Sciences University, Portland, OR, USA), the CMV-Fra-2 construct was obtained from Donna Cohen (The Australian University, Canberra, Australia). The synthesis and puri®cation of CREB and the A-ZIP DN proteins has been described previously (Olive et al., 1997; Ahn et al., 1998) . Polyclonal rabbit antibody directed against CREB and CREMa were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA); polyclonal rabbit antibodies against CREB and phospho-ser 133 CREB obtained from Upstate Biotechnology (Lake Placid, NY, USA) were also used in this study. The mouse monoclonal ATF-1 antibody was obtained from Santa Cruz Biotechnology. The Mpeptide antibody (Fisher et al., 1991) was obtained from Dr M Iadorola (National Institute for Dental Research) and the remaining antibodies directed against the AP-1 proteins that were used in this study have been described previously (Rutberg et al., 1997) .
Statistical analysis
To compare treatments and eects of expression vextors, geometric means were calculated for replicates of the reporter plasmid and for replicates of the matched control plasmid (pBLCAT2), and the ratio of the test to control geometric means was then calculated for each group. The test/control ratios were log-transformed, and two-tailed ttests used to compare the eect of dierent treatments to controls. Signi®cance was set at P=0.05.
